Nadim Ahmed
2022
In 2022, Nadim Ahmed earned a total compensation of $3.9M as President and Chief Executive Officer at Cullinan Therapeutics, a 90% decrease compared to previous year.
Compensation breakdown
| Bonus | $370,800 |
|---|---|
| Salary | $618,000 |
| Stock Awards | $2,762,750 |
| Other | $148,977 |
| Total | $3,900,527 |
Ahmed received $2.8M in stock awards, accounting for 71% of the total pay in 2022.
Ahmed also received $370.8K in bonus, $618K in salary and $149K in other compensation.
Rankings
In 2022, Nadim Ahmed's compensation ranked 894th out of 5,760 executives tracked by ExecPay. In other words, Ahmed earned more than 84.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 894 out of 5,760 | 85th |
Division Manufacturing | 407 out of 3,136 | 87th |
Major group Chemicals And Allied Products | 143 out of 1,422 | 90th |
Industry group Drugs | 129 out of 1,323 | 90th |
Industry Biological Products, Except Diagnostic Substances | 27 out of 291 | 91st |
Source: SEC filing on April 21, 2023.
Ahmed's colleagues
We found two more compensation records of executives who worked with Nadim Ahmed at Cullinan Therapeutics in 2022.